Viewing Study NCT00002866


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-02-07 @ 10:51 AM
Study NCT ID: NCT00002866
Status: COMPLETED
Last Update Posted: 2020-04-01
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Sponsor: NCIC Clinical Trials Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Neutropenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV breast cancer View
None recurrent breast cancer View
None neutropenia View